Source: CBS Sacramento
Ranbaxy Pharmaceuticals Inc. is recalling more than 40 lots of atorvastatin pills — the generic version of the popular statin Lipitor — over possible glass contamination.
Statins, or lipid-lowering drugs, are among the most commonly prescribed medications in the United States. The drug Lipitor was hugely popular for Pfizer until the company’s patent expired in November 2011.
A generic version of the drug is now being recalled by the India-based Ranbaxy because small glass particles approximately less than 1 millimeter in size may be in select batches, the company said on its U.S. website.
The company’s voluntary recall affects certain lot numbers of 10 milligram, 20 milligram and 40 milligram dosage strengths of atorvastatin calcium pills that are packaged in 90- and 500-count bottles. Ranbaxy said the recall is being conducted with knowledge of the U.S. Food and Drug Administration.
To read this article in its entirety visit CBS Sacramento.